Skip to main content
Log in

Impact of diet restriction in the management of diabetes: evidences from preclinical studies

  • Review
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The inappropriate dietary habits lead to the onset of age-related pathologies which include diabetes and cardiovascular ailments. Dietary restriction and nutritional therapy play an important role in the prevention of these chronic ailments. Preclinical research provides a basis for the therapeutic exploration of new dietary interventions for the clinical trials to potentiate the scientific management of diabetes and its related complications which further help in translating these nutritional improvements from bench to bedside. Within the same context, numerous therapeutically proved preclinical dietary interventions like high-fiber diet, caloric restriction, soy isoflavone-containing diets, etc., have shown the promising results for the management of diabetes and the associated complications. The focus of the present review is to highlight the various preclinical evidences of diet restriction for the management of diabetes and which will be helpful for enlightening the new ideas of nutritional therapy for future research exploration. In addition, some potential approaches are also discussed which are associated with various nutritional interventions to combat progressive diabetes and the associated disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AGES:

Advanced glycation end products

AMPK:

AMP-activated protein kinase

CR:

Caloric restriction

DN:

Diabetic nephropathy

DNA:

Deoxyribonucleic acid

DR:

Dietary restriction

ET:

Exercise training

GLUT2:

Glucose transporter 2

HbAIC:

Hemoglobin A1c or glycated hemoglobin

HDL:

High-density lipoprotein

HFD:

High-fat diet

IGF-1:

Insulin-like growth factor 1

KD:

Ketogenic diet

LCKD:

Low-carbohydrate ketogenic diet

LDL:

Low-density lipoprotein

LFSMP:

Low-fat soy milk powder

MDA:

Malondialdehyde

MNT:

Medical nutrition therapy

mTORC1:

Mammalian target of rapamycin complex 1

NAD+:

Nicotinamide adenine dinucleotide

OLETF:

Otsuka-Long-Evans-Tokushima fatty

PPAR:

Peroxisome proliferator-activated receptor

SIRT:

Sirtuins

STZ:

Streptozotocin

T2DM:

Type 2 diabetes mellitus

TG:

Triglyceride

WHO:

World Health Organization

References

Download references

Acknowledgements

We want to acknowledge the Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala and UGC, New Delhi for extending the necessary research facilities for our work. We also want to acknowledge Elegant Foreign Language Institute (EFLI) IELTS Institute Sunam, Punjab, India for English writing and editing.

Funding

The authors are thankful to DST-SERB, New Delhi for providing financial assistance under project no. EMR/2014/000438 to accomplish this research work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pawan Krishan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Chemical compounds studied in this article

Streptozotocin (PubChem CID:29327)

Highlights

• Diet restriction has beneficial effects on insulin action and glycemic control in obesity and mild T2DM

• Soy diet shown to produce anti-diabetic effect by acting through the estrogen receptors.

• Preclinical evidences of diet restriction and dietary approaches in the management of diabetes and their associated complications.

• Other highlight of this review is about nutritional interventions which combat progressive diabetes and the associated disorders.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krishan, P., Bedi, O. & Rani, M. Impact of diet restriction in the management of diabetes: evidences from preclinical studies. Naunyn-Schmiedeberg's Arch Pharmacol 391, 235–245 (2018). https://doi.org/10.1007/s00210-017-1453-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-017-1453-5

Keywords

Navigation